Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Immunogenicity of MenABCWY in Healthy Infants
NCT04645966Phase 2Terminated
- Sponsor
- Pfizer
- Start
- Nov 2020
- Primary completion
- Sep 2022
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 3
01
Overview
A Phase 2 trial of Meningococcal ABCYW vaccine in meningococcal disease, sponsored by Pfizer. Started Nov 2020; status: terminated.
02
Drugs
Meningococcal ABCYW vaccine
03
Conditions
meningococcal disease
Beyond the preview
Go deeper on NCT04645966.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04645966.